array:23 [ "pii" => "S021491680478972X" "issn" => "02149168" "doi" => "10.1016/S0214-9168(04)78972-X" "estado" => "S300" "fechaPublicacion" => "2004-01-01" "aid" => "78972" "copyright" => "Sociedad Española de Arteriosclerosis y Elsevier España, S.L." "copyrightAnyo" => "2003" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edi" "cita" => "Clin Invest Arterioscl. 2004;16:111-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1602 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 1355 "PDF" => 239 ] ] "itemSiguiente" => array:18 [ "pii" => "S0214916804789731" "issn" => "02149168" "doi" => "10.1016/S0214-9168(04)78973-1" "estado" => "S300" "fechaPublicacion" => "2004-01-01" "aid" => "78973" "copyright" => "Sociedad Española de Arteriosclerosis y Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Clin Invest Arterioscl. 2004;16:114-21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4395 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 3861 "PDF" => 527 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Hierro, resistencia a la insulina y riesgo cardiovascular" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "114" "paginaFinal" => "121" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Iron, insulin resistance and cardiovascular risk" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.M. Fernández-Real, E. Esteve, W. Ricart" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Fernández-Real" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Esteve" ] 2 => array:2 [ "nombre" => "W." "apellidos" => "Ricart" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916804789731?idApp=UINPBA00004N" "url" => "/02149168/0000001600000003/v1_201307111120/S0214916804789731/v1_201307111120/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0214916804789718" "issn" => "02149168" "doi" => "10.1016/S0214-9168(04)78971-8" "estado" => "S300" "fechaPublicacion" => "2004-01-01" "aid" => "78971" "copyright" => "Sociedad Española de Arteriosclerosis y Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edi" "cita" => "Clin Invest Arterioscl. 2004;16:108-10" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2160 "formatos" => array:3 [ "EPUB" => 9 "HTML" => 1735 "PDF" => 416 ] ] "es" => array:7 [ "idiomaDefecto" => true "titulo" => "Metabolismo férrico y enfermedad cardiovascular" "tienePdf" => "es" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "108" "paginaFinal" => "110" ] ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Joven" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Joven" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916804789718?idApp=UINPBA00004N" "url" => "/02149168/0000001600000003/v1_201307111120/S0214916804789718/v1_201307111120/es/main.assets" ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Efectos complementarios de las terapias farmacológicas" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "111" "paginaFinal" => "113" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J. Ribalta" "autores" => array:1 [ 0 => array:4 [ "nombre" => "J." "apellidos" => "Ribalta" "email" => array:1 [ 0 => "jrv@fmcs.urv.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Unitat de Recerca de Lípids i Arteriosclerosi. Facultat de Medicina. Institut de Recerca de Ciències de la Salut. Universitat Rovira i Virgili. Reus. Tarragona. España" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondencia: Unitat de Recerca de Lípids i Arteriosclerosi. Facultat de Medicina. Institut de Recerca de Ciències de la Salut. Universitat Rovira i Virgili. Sant Llorenç, 21. 43201 Reus. Tarragona. España." ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2003-01-27" "fechaAceptado" => "2003-01-27" "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:17 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thiazolidinediones: an update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Schoonjans" 1 => "J. Auwerx" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(00)90002-3" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2000" "volumen" => "355" "paginaInicial" => "1008" "paginaFinal" => "1010" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10768450" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Statin-induced inhibition of the Rho-signaling pathway activates PPARa and induces HDL apoA-I" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Martin" 1 => "H. Duez" 2 => "C. Blanquart" 3 => "V. Berezowski" 4 => "P. Poulain" 5 => "J.C. Fruchart" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1172/JCI10852" "Revista" => array:6 [ "tituloSerie" => "J Clin Invest" "fecha" => "2001" "volumen" => "107" "paginaInicial" => "1423" "paginaFinal" => "1432" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11390424" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.M. Haffner" 1 => "A.S. Greenberg" 2 => "W.M. Weston" 3 => "H. Chen" 4 => "K. Williams" 5 => "M.I. Freed" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2002" "volumen" => "106" "paginaInicial" => "679" "paginaFinal" => "684" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12163427" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Simvastatin decreases aldehyde production derived from lipoprotein oxidation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Girona" 1 => "A.E. La Ville" 2 => "R. Solà" 3 => "N. Plana" 4 => "L. Masana" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "1999" "volumen" => "83" "paginaInicial" => "846" "paginaFinal" => "851" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10190397" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The control of bone growth by parathyroid hormone, leptin, & statins" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.F. Whitfield" 1 => "P. Morley" 2 => "G.E. Willick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Rev Eukaryot Gene Expr" "fecha" => "2002" "volumen" => "12" "paginaInicial" => "23" "paginaFinal" => "51" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12433064" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efectos de la combinación rosiglitazona- atorvastatina sobre la expresión de genes implicados en la captación y en la salida de colesterol en el macrófago" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Llaverías" 1 => "D. Lacasa" 2 => "M. Alegret" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Invest Arterioscler" "fecha" => "2004" "volumen" => "16" "numero" => "1" "paginaInicial" => "10" "paginaFinal" => "17" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucoselowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.A. Alsheikh" 1 => "H.M. Abourjaily" 2 => "R.H. Karas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2002" "volumen" => "89" "paginaInicial" => "1308" "paginaFinal" => "1310" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12031736" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "on behalf of the Rosiglitazone Study 108 Investigators. Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.I. Freed" 1 => "R. Ratner" 2 => "S.M. Marcovina" 3 => "M.M. Kreider" 4 => "N. Biswas" 5 => "B.R. Cohen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2002" "volumen" => "90" "paginaInicial" => "947" "paginaFinal" => "952" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12398960" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of PPAR-g in macrophage differentiation and cholesterol uptake" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.J. Moore" 1 => "E.D. Rosen" 2 => "M.L. Fitzgerald" 3 => "F. Randow" 4 => "L.P. Andersson" 5 => "D. Altshuler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/83328" "Revista" => array:6 [ "tituloSerie" => "Nat Med" "fecha" => "2001" "volumen" => "7" "paginaInicial" => "41" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11135614" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The peroxisome proliferatoractivated receptor delta promotes lipid accumulation in human macrophages" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H. Vosper" 1 => "L. Patel" 2 => "T.L. Graham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1074/jbc.M108482200" "Revista" => array:6 [ "tituloSerie" => "J Biol Chem" "fecha" => "2001" "volumen" => "276" "paginaInicial" => "44258" "paginaFinal" => "44265" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11557774" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Avasimide and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Llaverías" 1 => "M. Jové" 2 => "M. Vázquez-Carrera" 3 => "R. Sánchez" 4 => "C. Díaz" 5 => "G. Hernández" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Pharmacol" "fecha" => "2002" "volumen" => "451" "paginaInicial" => "11" "paginaFinal" => "17" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12223223" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.C. Whitman" 1 => "D.L. Rateri" 2 => "S.J. Szilvassy" 3 => "J.A. Cornicelli" 4 => "A. Daugherty" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Lipid Res" "fecha" => "2002" "volumen" => "43" "paginaInicial" => "1201" "paginaFinal" => "1208" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12177164" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ppargamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Tontonoz" 1 => "L. Nagy" 2 => "J.G. Álvarez" 3 => "V.A. Thomazy" 4 => "R.M. Evans" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cell" "fecha" => "1998" "volumen" => "93" "paginaInicial" => "241" "paginaFinal" => "252" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9568716" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.C. Vallvé" 1 => "K. Uliaque" 2 => "J. Girona" 3 => "A. Cabré" 4 => "J. Ribalta" 5 => "M. Heras" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2002" "volumen" => "164" "paginaInicial" => "45" "paginaFinal" => "56" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12119192" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fatty acids modulate the effect of darglitazone on macrophage CD36 expression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Svensson" 1 => "G. Camejo" 2 => "A. Cabré" 3 => "J.C. Vallvé" 4 => "J. Pedreño" 5 => "K. Norén" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Invest" "fecha" => "2003" "volumen" => "33" "paginaInicial" => "464" "paginaFinal" => "471" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12795642" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ppara and Pparg activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Chinetti" 1 => "S. Lestavel" 2 => "V. Bocher" 3 => "A.T. Remaley" 4 => "B. Neve" 5 => "I. Pineda Torra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/83348" "Revista" => array:6 [ "tituloSerie" => "Nat Med" "fecha" => "2001" "volumen" => "7" "paginaInicial" => "53" "paginaFinal" => "58" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11135616" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Task force on strategic research direction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Bonow" 1 => "E.B. Clark" 2 => "G.D. Curfman" 3 => "A. Guttmacher" 4 => "M.N. Hill" 5 => "G. Miller" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2002" "volumen" => "106" "paginaInicial" => "e162" "paginaFinal" => "e166" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12427671" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02149168/0000001600000003/v1_201307111120/S021491680478972X/v1_201307111120/es/main.assets" "Apartado" => array:4 [ "identificador" => "15110" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editoriales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02149168/0000001600000003/v1_201307111120/S021491680478972X/v1_201307111120/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021491680478972X?idApp=UINPBA00004N" ]
Información de la revista
Vol. 16. Núm. 3.
Páginas 111-113 (enero 2004)
Vol. 16. Núm. 3.
Páginas 111-113 (enero 2004)
Acceso a texto completo
Efectos complementarios de las terapias farmacológicas
Visitas
2364
J. Ribalta
Autor para correspondencia
jrv@fmcs.urv.es
Correspondencia: Unitat de Recerca de Lípids i Arteriosclerosi. Facultat de Medicina. Institut de Recerca de Ciències de la Salut. Universitat Rovira i Virgili. Sant Llorenç, 21. 43201 Reus. Tarragona. España.
Correspondencia: Unitat de Recerca de Lípids i Arteriosclerosi. Facultat de Medicina. Institut de Recerca de Ciències de la Salut. Universitat Rovira i Virgili. Sant Llorenç, 21. 43201 Reus. Tarragona. España.
Unitat de Recerca de Lípids i Arteriosclerosi. Facultat de Medicina. Institut de Recerca de Ciències de la Salut. Universitat Rovira i Virgili. Reus. Tarragona. España
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
K. Schoonjans, J. Auwerx.
Thiazolidinediones: an update.
Lancet, 355 (2000), pp. 1008-1010
[2.]
G. Martin, H. Duez, C. Blanquart, V. Berezowski, P. Poulain, J.C. Fruchart, et al.
Statin-induced inhibition of the Rho-signaling pathway activates PPARa and induces HDL apoA-I.
J Clin Invest, 107 (2001), pp. 1423-1432
[3.]
S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, M.I. Freed.
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Circulation, 106 (2002), pp. 679-684
[4.]
J. Girona, A.E. La Ville, R. Solà, N. Plana, L. Masana.
Simvastatin decreases aldehyde production derived from lipoprotein oxidation.
Am J Cardiol, 83 (1999), pp. 846-851
[5.]
J.F. Whitfield, P. Morley, G.E. Willick.
The control of bone growth by parathyroid hormone, leptin, & statins.
Crit Rev Eukaryot Gene Expr, 12 (2002), pp. 23-51
[6.]
G. Llaverías, D. Lacasa, M. Alegret.
Efectos de la combinación rosiglitazona- atorvastatina sobre la expresión de genes implicados en la captación y en la salida de colesterol en el macrófago.
Clin Invest Arterioscler, 16 (2004), pp. 10-17
[7.]
A.A. Alsheikh, H.M. Abourjaily, R.H. Karas.
Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucoselowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose.
Am J Cardiol, 89 (2002), pp. 1308-1310
[8.]
M.I. Freed, R. Ratner, S.M. Marcovina, M.M. Kreider, N. Biswas, B.R. Cohen, et al.
on behalf of the Rosiglitazone Study 108 Investigators. Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus.
Am J Cardiol, 90 (2002), pp. 947-952
[9.]
K.J. Moore, E.D. Rosen, M.L. Fitzgerald, F. Randow, L.P. Andersson, D. Altshuler, et al.
The role of PPAR-g in macrophage differentiation and cholesterol uptake.
Nat Med, 7 (2001), pp. 41-47
[10.]
H. Vosper, L. Patel, T.L. Graham, et al.
The peroxisome proliferatoractivated receptor delta promotes lipid accumulation in human macrophages.
J Biol Chem, 276 (2001), pp. 44258-44265
[11.]
G. Llaverías, M. Jové, M. Vázquez-Carrera, R. Sánchez, C. Díaz, G. Hernández, et al.
Avasimide and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages.
Eur J Pharmacol, 451 (2002), pp. 11-17
[12.]
S.C. Whitman, D.L. Rateri, S.J. Szilvassy, J.A. Cornicelli, A. Daugherty.
Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology.
J Lipid Res, 43 (2002), pp. 1201-1208
[13.]
Tontonoz, L. Nagy, J.G. Álvarez, V.A. Thomazy, R.M. Evans.
Ppargamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.
Cell, 93 (1998), pp. 241-252
[14.]
J.C. Vallvé, K. Uliaque, J. Girona, A. Cabré, J. Ribalta, M. Heras, et al.
Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages.
Atherosclerosis, 164 (2002), pp. 45-56
[15.]
L. Svensson, G. Camejo, A. Cabré, J.C. Vallvé, J. Pedreño, K. Norén, et al.
Fatty acids modulate the effect of darglitazone on macrophage CD36 expression.
Eur J Clin Invest, 33 (2003), pp. 464-471
[16.]
G. Chinetti, S. Lestavel, V. Bocher, A.T. Remaley, B. Neve, I. Pineda Torra, et al.
Ppara and Pparg activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.
Nat Med, 7 (2001), pp. 53-58
Copyright © 2003. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.